Thanks sox. It was nice of Cabel to share his email. I'm flexible, and I certainly have the patience. Things can happen quickly once we see prurisol topline data. By the end of this month, though how long it really takes is beyond our (Leo's) control. And then we'll still be waiting on full data for both brilacidin and prurisol. Throw in maybe some news on kevetrin as well maybe.

I still think prurisol meets/exceeds. 60% + chance imo. Marketable.

Compassionate use for both. Brilacidin should still be able to get breakthrough designation as well. Need to rock and roll, kick the tires and light the fires on the scientists and all involved and get that puppy rolling.